Literature DB >> 15763001

Is stone radiodensity a useful parameter for predicting outcome of extracorporeal shockwave lithotripsy for stones < or = 2 cm?

Mina S Krishnamurthy1, Paul G Ferucci, Noel Sankey, Paramjit S Chandhoke.   

Abstract

PURPOSE: Several factors determine the success of extracorporeal shockwave lithotripsy (SWL) for kidney stones: stone size, stone location within the collecting system, stone type, and the SWL machine used. It has been suggested that stone radiodensity, as determined either by plain radiography or computed tomography attenuation values, may be an independent predictor of SWL success. We examined the outcome of SWL for solitary stones less than or equal to 2 cm located within the renal pelvis, based on their radiodensity.
MATERIAL AND METHODS: 211 patients with solitary renal pelvic stones measuring less than or equal to 2 cm were treated on a Dornier Doli 50 lithotriptor under general anesthesia. The radiodensity of the stone was determined to be either less than, equal to, or greater than the radiodensity of the ipsilateral 12th rib. Stone-free rates (SFR) were determined at 3 months by kidney, ureters and bladder (KUB) plain X-rays. Patients requiring re-treatment or auxiliary procedures were considered failures of SWL.
RESULTS: Follow-up SFR information was available in all 211 patients. Stone composition was available in 158 (75%) treated patients, but no correlation was found between stone radiodensity and stone composition. For stones < or = 10 mm within the renal pelvis, the SFRs were similar (71 to 74% regardless of stone radiodensity). For stones between 11 and 20 mm, the SFR was 60% if the stone had a radiodensity > 12th rib compared to a SFR of 71% if the stone radiodensity was < or = 12th rib. However, these differences in SFRs were not statistically significant.
CONCLUSIONS: On the Doli machine, stone radiodensity alone does not predict lithotripsy treatment outcome for stones < or = 1 cm within the renal pelvis. This parameter is probably only useful as the stone size becomes larger than 1 cm, and should be used in conjunction with other stone parameters to select appropriate therapy.

Entities:  

Mesh:

Year:  2005        PMID: 15763001     DOI: 10.1590/s1677-55382005000100002

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  7 in total

Review 1.  Assessment of stone composition in the management of urinary stones.

Authors:  Kittinut Kijvikai; J J M de la Rosette
Journal:  Nat Rev Urol       Date:  2010-12-07       Impact factor: 14.432

2.  Diagnostic utility of attenuation measurement (Hounsfield units) in computed tomography stonogram in predicting the radio-opacity of urinary calculi in plain abdominal radiographs.

Authors:  Michael E Chua; Glenn T Gatchalian; Michael Vincent Corsino; Buenaventura B Reyes
Journal:  Int Urol Nephrol       Date:  2012-05-12       Impact factor: 2.370

3.  Use of computed tomography scout film and Hounsfield unit of computed tomography scan in predicting the radio-opacity of urinary calculi in plain kidney, ureter and bladder radiographs.

Authors:  Michael E Chua; Odina R Gomez; Lorelei D Sapno; Steve L Lim; Marcelino L Morales
Journal:  Urol Ann       Date:  2014-07

4.  Cystine calculi: correlation of CT-visible structure, CT number, and stone morphology with fragmentation by shock wave lithotripsy.

Authors:  Samuel C Kim; Erin K Burns; James E Lingeman; Ryan F Paterson; James A McAteer; James C Williams
Journal:  Urol Res       Date:  2007-10-27

Review 5.  Predicting stone composition before treatment - can it really drive clinical decisions?

Authors:  Ewa Bres-Niewada; Bartosz Dybowski; Piotr Radziszewski
Journal:  Cent European J Urol       Date:  2014-12-05

6.  Management of 1-2 cm renal stones.

Authors:  Aneesh Srivastava; Saurabh S Chipde
Journal:  Indian J Urol       Date:  2013-07

7.  Has the pelvic renal stone position inside the upper loop of JJ stent any influence on the extracorporeal shock wave lithotripsy results?

Authors:  Catalin Pricop; Dragomir N Serban; Ionela Lacramioara Serban; Alin-Adrian Cumpanas; Constantin-Virgil Gingu
Journal:  Springerplus       Date:  2016-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.